Balanced news tone
News Sentiment
NVS sentiment intelligence
Novartis AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-10.2% over one week, +5.4% over four weeks, trend active, and materially above fair value.
Novartis AG (TSX:NVS) Stock Price, Trades & News
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Novartis AG (TSX:NVS) Stock Price, Trades & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 01:28
- Source
- GuruFocus
Gear Up for Novartis (NVS) Q2 Earnings: Wall Street Estimates for Key Metrics
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 13:15
- Source
- Market source
NVS News | NOVARTIS AG-SPONSORED ADR (NYSE:NVS)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 10:23
- Source
- ChartMill
Why Novartis (NVS) Stock Fell Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Quiver Quantitative
Novartis AG (NVS) Stock Up 3.7% but GF Value Says Overvalued -- GF Score: 82/100
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 21:34
- Source
- GuruFocus
Novartis AG Stock (NVS) Moved Up by 3.39% on Jul 2: A Full Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- TradingKey
Novartis Plays Long Game With Antares Deal - Meaning Near-Term Upside Unlikely (NYSE:NVS)
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 25 Jun 2026 07:00
- Source
- Seeking Alpha
Novartis AG (NVS): 7 Best Longevity and Anti-Aging Stocks to Buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Market source
Selling pressure pushes Novartis stock lower in today's trading
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- Traders Union
Novartis AG Stock (NVS) Moved Up by 4.20% on Jun 11: What Investors Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- TradingKey
Novartis AG Stock (NVS) Moved Down by 3.14% on Jun 1: Key Drivers Unveiled
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- TradingKey
Novartis (NVS) Positioned for Growth Through Transformative Innovations
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Market source
Novartis Canada launches third edition of its Health Equity Initiative, prioritizing Women’s Health
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2026 21:23
- Source
- Novartis
Novartis AG (NVS) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 83/100
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- GuruFocus
Novartis (NVS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Apr 2026 07:00
- Source
- Market source
Novartis Q1 Earnings & Revenues Miss Estimates, Stock Down
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 28 Apr 2026 07:00
- Source
- Market source
Novartis AG (NVS): One of the Best Low Risk High Growth Plays on the Market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Apr 2026 07:00
- Source
- Market source
Shares of Novartis hit upper circuit after the Swiss pharma major Novartis said it plans to sell 70% stake in its India unit to Chrys capital for nearly 1,500 crore rupees. Chrys capital will also make an open offer for an additional 26% stake. Ekta Batra brings us m
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 20 Feb 2026 08:00
- Source
Exploring Analyst Estimates for Novartis (NVS) Q4 Earnings, Beyond Revenue and EPS
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Jan 2026 08:00
- Source
- Market source
Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock Backed by Strong Fundamentals
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 23 Jan 2026 08:00
- Source
- ChartMill
Novartis announces commencement of tender offer to acquire Tourmaline Bio
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Sep 2025 07:00
- Source
- Novartis
Novartis announces commencement of tender offer to acquire Regulus Therapeutics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2025 12:07
- Source
- Novartis
Novartis split complete as Sandoz begins trading on Swiss Exchange
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Oct 2023 07:00
- Source
- Pharmaceutical Technology
Novartis Has a Big Pile of Cash and Investors Are Demanding Action
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 18 Nov 2021 08:00
- Source
- Bloomberg.com
Novartis AG (NVS) Stock Price, Trades & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Apr 2019 21:08
- Source
- GuruFocus
Novartis CEO's $50 Billion of Deals Was Just the First Act
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Apr 2019 07:00
- Source
- Bloomberg.com